D. Anthony Rawlings

Discovery of 2-[(2,4-Dichlorophenyl)amino]- <i>N</i> -[(tetrahydro- 2 <i>H</i> -pyran-4-yl)methyl]-4-(trifluoromethyl)- 5-pyrimidinecarboxamide, a Selective CB2 Receptor Agonist for the Treatment of Inflammatory Pain

Gerard M.P. Giblin, Celestine T. O’Shaughnessy, Alan Naylor et al. · Journal of Medicinal Chemistry · 2007 · 120 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Isocytosine H2-receptor histamine antagonists I. Oxmetidine and related compounds

Thomas H. Brown, R. C. Blakemore, Graham J. Durant et al. · European Journal of Medicinal Chemistry · 1988 · 41 citations

Medicine, Medicinal Chemistry, Pharmacology +5

Potent, orally active inhibitors of lipoprotein-associated phospholipase A2: 1-(biphenylmethylamidoalkyl)-pyrimidones

Helen Boyd, Stephen C. M. Fell, Deirdre M. B. Hickey et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 29 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8

N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2

Helen Boyd, Stephen C. M. Fell, Sean T. Flynn et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 28 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +6

Discovery of GSK345931A: An EP1 receptor antagonist with efficacy in preclinical models of inflammatory pain

Adrian Hall, Susan H. Brown, Nicholas M. Clayton et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 27 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15